| 2015 | Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
| CANCER RESEARCH AND TREATMENT |
| 2015 | Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2015 | PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer | ONCOLOGY |
| 2014 | The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. | MOLECULAR CANCER THERAPEUTICS |
| 2014 | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. | LANCET ONCOLOGY |
| 2014 | Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2014 | High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
| WORLD JOURNAL OF SURGICAL ONCOLOGY |
| 2014 | Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2014 | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial | INVESTIGATIONAL NEW DRUGS |
| 2014 | Quality of Life in the Trastuzumab for Gastric Cancer Trial | ONCOLOGIST |
| 2014 | Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study | JOURNAL OF CLINICAL ONCOLOGY |
| 2014 | A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer | INVESTIGATIONAL NEW DRUGS |
| 2014 | Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer | PATHOLOGY |
| 2014 | Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer | JOURNAL OF PSYCHOSOMATIC RESEARCH |
| 2014 | Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
| JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2013 | Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial | JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study | JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
| BMC CANCER |
| 2013 | Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study | ANNALS OF SURGICAL ONCOLOGY |
| 2013 | Changing treatment patterns in elderly patients with resectable colon cancer | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. | ANTICANCER RESEARCH |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| SUPPORTIVE CARE IN CANCER |
| 2013 | Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer | JOURNAL OF MOLECULAR DIAGNOSTICS |
| 2013 | Therapeutic Strategies for Well-differentiated Papillary Mesothelioma of the Peritoneum
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial | LANCET ONCOLOGY |
| 2013 | Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer
| BMC CANCER |
| 2013 | Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic Tool | ANNALS OF SURGICAL ONCOLOGY |
| 2013 | Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study | JOURNAL OF SURGICAL ONCOLOGY |
| 2013 | Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2013 | Increased Alternative Lengthening of Telomere Phenotypes of Telomerase-negative Immortal Cells upon Trichostatin – A Treatment | ANTICANCER RESEARCH |
| 2013 | Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. | NATURE MEDICINE |
| 2013 | Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer
| JOURNAL OF RADIATION RESEARCH |
| 2013 | Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent | INVESTIGATIONAL NEW DRUGS |
| 2012 | Body image, sexual function and depression in Korean patients with breast cancer: modification by 5-HTT polymorphism | SUPPORTIVE CARE IN CANCER |
| 2012 | FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: a controlled and prospective study | PSYCHONEUROENDOCRINOLOGY |
| 2012 | Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy
| PLOS ONE |
| 2012 | High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection
| ONCOLOGY LETTERS |
| 2012 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. | LANCET |
| 2012 | Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group | JOURNAL OF CLINICAL ONCOLOGY |
| 2012 | A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy. | INVESTIGATIONAL NEW DRUGS |
| 2012 | A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy. | INVESTIGATIONAL NEW DRUGS |
| 2012 | A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer | INVESTIGATIONAL NEW DRUGS |
| 2012 | Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer. | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2012 | Methylation status of lamin A/C in gastric cancer cell lines. | HEPATO-GASTROENTEROLOGY |
| 2012 | A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.
| GUT |
| 2012 | A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer. | EUROPEAN JOURNAL OF CANCER |
| 2012 | AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer.
| CANCER RESEARCH |
| 2012 | Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells.
| BMC GENOMICS |
| 2012 | Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience.
| BMC CANCER |
| 2012 | Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
http://orcid.org/0000-0002-0920-9471
(7404006815)
